What are Malaria Rapid Diagnostic Tests (RDTs)?

Malaria RDTs are diagnostic tools used to quickly and accurately detect the presence of malaria parasites in a patient's blood. They are essential for early diagnosis and treatment of malaria.

How big is the Malaria Rapid Diagnostic Tests (RDTS) Market?

The global Malaria Rapid Diagnostic Tests (RDTS) Market size was estimated at USD 442.0 Million in 2023 and is expected to reach USD 726.9 Million in 2033.

What is the Malaria Rapid Diagnostic Tests (RDTS) Market growth?

The global Malaria Rapid Diagnostic Tests (RDTS) Market is expected to grow at a compound annual growth rate of 5.1%. From 2024 To 2033.

Who are the key companies/players in the Malaria Rapid Diagnostic Tests (RDTS) Market?

Some of the key players in the Malaria Rapid Diagnostic Tests (RDTS) Markets are Abbott Laboratories, Apacor Ltd., Arkray, Atomo Diagnostics, Biosynex, Recombigen Laboratories Private Limited, Triveni Traders & Diagnostic Private Limited, Cupid Limited, Levram Life Sciences Private Limited, Green Grapes Diagnostics, Other Key Players.

How do Malaria RDTs work?

These tests typically use a small blood sample from a patient and detect specific malaria antigens or proteins. The presence of these antigens indicates an active malaria infection.

Why are Malaria RDTs important?

Malaria RDTs are crucial for timely and accurate diagnosis, especially in regions with limited access to laboratories. They enable rapid identification of malaria cases, aiding in prompt treatment and reducing the spread of the disease.

What are the advantages of Malaria RDTs over traditional methods like microscopy?

Malaria RDTs offer quick results, require minimal training to use, and are suitable for point-of-care testing, making them more accessible in remote areas. They also have a lower risk of human error compared to microscopy.

Global Malaria Rapid Diagnostic Tests (RDTS) Market By Type (Single Species Detection, Multiple Species Detection) End-User (Hospitals, Clinics, Others) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033

Published date: July 2024
Report ID: 28131
Number of Pages: 306
Format:

- Abbott Laboratories
- Apacor Ltd.
- Arkray
- Atomo Diagnostics
- Biosynex
- Recombigen Laboratories Private Limited
- Triveni Traders & Diagnostic Private Limited
- Cupid Limited
- Levram Life Sciences Private Limited
- Green Grapes Diagnostics
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Malaria Rapid Diagnostic Tests (RDTS) Market

Report ID 28131
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (59)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)